https://allsci.com/news/venture-financing/hepatitis-b-therapy-funding-ausperbio-raises-usd/ AllScien 2026-08-28T14:39:42.715719Z AusperBio raises USD 120m Series C for late-stage hepatitis B antisense therapy https://allsci.com/news/approvals/bixlenvo-fda-approval-hiv-approves-gileads-for/ AllScien 2026-08-28T14:22:33.786454Z FDA approves Gilead's Bixlenvo to simplify complex HIV regimens https://allsci.com/news/clinical-trials/paxalisib-triple-negative-breast-cancer/ AllScien 2026-08-28T08:09:20.713343Z Kazia touts 100% clinical benefit rate for paxalisib in early-stage TNBC study https://allsci.com/news/licensing-and-partnerships/combination-flu-vaccine-osivax-pairs-phase-ii/ AllScien 2026-08-28T07:56:31.860607Z Osivax pairs Phase II flu vaccine with GC Biopharma's marketed shot in combination deal https://allsci.com/news/regulatory/fda-approves-covid-19-vaccines-2026-modernas/ AllScien 2026-08-28T07:46:45.320373Z FDA approves Moderna's updated 2026-2027 COVID-19 vaccines for high-risk and older adults https://allsci.com/news/licensing-and-partnerships/genentech-dualitybio-adc-collaboration-taps/ AllScien 2026-08-28T07:39:44.492166Z Genentech taps DualityBio's DUPAC platform for multi-program ADC collaboration https://allsci.com/news/research/shingles-vaccine-cardiovascular-risk-recombinant/ AllScien 2026-08-28T07:33:36.695576Z Shingrix shows potential cardiovascular benefit in US natural experiment https://allsci.com/news/regulatory/skyrizi-crohns-disease-ema-abbvie-seeks-approval/ AllScien 2026-08-27T12:34:22.863778Z AbbVie seeks EMA approval for Skyrizi subcutaneous induction in Crohn's disease https://allsci.com/news/clinical-trials/tezspire-eosinophilic-esophagitis-extends-tslp/ AllScien 2026-08-27T11:56:34.451842Z Amgen/AZ's Tezspire extends TSLP platform to eosinophilic esophagitis with Phase III win